Provided by Tiger Fintech (Singapore) Pte. Ltd.

Applied Therapeutics Inc.

0.3700
+0.02607.56%
Post-market: 0.3551-0.0149-4.03%18:26 EDT
Volume:2.65M
Turnover:943.70K
Market Cap:52.38M
PE:-0.49
High:0.3750
Open:0.3605
Low:0.3440
Close:0.3440
Loading ...

Applied Therapeutics’ NDA for govorestat receives negative response from FDA

TIPRANKS
·
28 Nov 2024

US FDA declines to approve Applied Therapeutics' genetic disease drug

Reuters
·
28 Nov 2024

Applied Therapeutics Inc - Expects to Submit an Nda Early in Q1 of 2025

THOMSON REUTERS
·
28 Nov 2024

Applied Therapeutics Inc - FDA Unable to Approve Govorestat Nda Due to Clinical Deficiencies

THOMSON REUTERS
·
28 Nov 2024

Applied Therapeutics Receives Complete Response Letter From U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia

THOMSON REUTERS
·
28 Nov 2024

Applied Therapeutics trading halted, news pending

TIPRANKS
·
28 Nov 2024

RBC says if Applied’s govorestat were to be approved, would likely hear today

TIPRANKS
·
28 Nov 2024

Here are 4 biotech stocks that could get a boost from Trump's new regulatory climate

Dow Jones
·
23 Nov 2024

Here are 4 biotech stocks that could get a boost from Trump's new regulatory climate

Dow Jones
·
20 Nov 2024

Biotech-stock investing has one tough test for success - and it's about to get easier

Dow Jones
·
18 Nov 2024

Applied Therapeutics (APLT) Gets a Buy from RBC Capital

TIPRANKS
·
09 Nov 2024

Applied Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
08 Nov 2024

Applied Therapeutics (APLT) Gets a Buy from William Blair

TIPRANKS
·
07 Nov 2024

BRIEF-Applied Therapeutics Reports Q3 2024 Financial Results

Reuters
·
07 Nov 2024

Applied Therapeutics Inc: Nda Submission for Govorestat for Treatment of Sord Deficiency Under Accelerated Approval Expected in Early Q1 2025

THOMSON REUTERS
·
07 Nov 2024

BRIEF-Morgan Stanley reports 8% passive stake in Applied Therapeutics Inc

Reuters
·
07 Nov 2024

Morgan Stanley Reports 8.0% Passive Stake in Applied Therapeutics Inc as of Sept 30 - SEC Filing

THOMSON REUTERS
·
07 Nov 2024

Applied Therapeutics call volume above normal and directionally bullish

TIPRANKS
·
31 Oct 2024

Applied Therapeutics (APLT) Upgraded to Buy: Here's What You Should Know

Zacks
·
30 Oct 2024

Is Applied Therapeutics (APLT) Outperforming Other Medical Stocks This Year?

Zacks
·
29 Oct 2024